Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
ReNAgade Therapeutics
ReNAgade Therapeutics
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
ReNAgade Therapeutics
Total Funding
$300 M
ReNAgade Therapeutics Summary
Company Summary
Overview
ReNAgade Therapeutics is a company that focuses on developing gene therapy technology. It develops and produces ribonucleic acid (RNA) medicines. The company provides a platform for coding, editing, and gene insertion tools in an all-RNA system.
Type
Private
Status
Active
Founded
2021
Website
https://renagadetx.com/
Cybersecurity rating
Sectors
Healthcare
biotech
genetics
platform
Homepage
Linkedin
twitter
Table of Contents
Competitors
Competitors and Similar Companies
InVivo Biosystems
Healthcare - Private
Ring Therapeutics
Healthcare - Private
Saphetor
Healthcare - Private
Depixus
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top